Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay
- 30 June 1993
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 11 (6) , 427-434
- https://doi.org/10.1016/0731-7085(93)80153-r
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Determination of a cyclic heptapeptide, a novel fibrinogen receptor antagonist, in human plasma by high-performance liquid chromatography with automated precolumn derivatization, column switching and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Platelet inhibitor agents in cardiovascular disease: An updateJournal of the American College of Cardiology, 1989
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Biochemical evidence of platelet activation in patients with persistent unstable anginaJournal of the American College of Cardiology, 1987
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Correlation between fibrinogen binding to human platelets and platelet aggregabilityBlood, 1980
- Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated plateletsNature, 1980
- The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassayBiochemical Journal, 1973